Interval cancers after negative immunochemical test compared to screen and non-responders’ detected cancers in Slovenian colorectal cancer screening programme

1Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. 10.1002/ijc.29210FerlayJSoerjomataramIDikshitREserSMathersCRebeloM.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer2015136E3598610.1002/ijc.29210Open DOISearch in Google Scholar

2Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-0008ZadnikVPrimic ZakeljMLokarKJarmKIvanusUZagarT.Cancer burden in Slovenia with the time trends analysisRadiol Oncol201751475510.1515/raon-2017-0008Open DOISearch in Google Scholar

3Proposal for a Council Recommendation on Cancer Screening. Commission of the European Communities. 2003/0093(CNS). [cited 2018 Mar 15]. Available from: http://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_en.pdfProposal for a Council Recommendation on Cancer ScreeningCommission of the European Communities2003/0093(CNS). [cited 2018 Mar 15]Available fromhttp://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_en.pdfSearch in Google Scholar

4Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71. 10.1056/NEJM199305133281901MandelJSBondJHChurchTRSnoverDCBradleyGMSchumanLMReducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control StudyN Engl J Med199332813657110.1056/NEJM199305133281901Open DOISearch in Google Scholar

5Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71. 10.1016/S0140-6736(96)03430-7KronborgOFengerCOlsenJJorgensenODSondergaardO.Randomised study of screening for colorectal cancer with faecal-occult-blood testLancet199634814677110.1016/S0140-6736(96)03430-7Open DOISearch in Google Scholar

6Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7. 10.1016/S0140-6736(96)03386-7HardcastleJDChamberlainJORobinsonMHMossSMAmarSSBalfourTWRandomised controlled trial of faecal-occult-blood screening for colorectal cancerLancet19963481472710.1016/S0140-6736(96)03386-7Open DOISearch in Google Scholar

7Segnan N, Patnick J, von Karsa L, editors. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. First edition. European Commission. Luxembourg: Publications Office of the European Union; 2010 [cited 2018 Mar 15]. Available from: http://www.stopdarmkanker.be/BOEKJE/boekEU.pdfSegnanNPatnickJvon KarsaLEuropean Guidelines for Quality Assurance in Colorectal Cancer Screening and DiagnosisFirstEuropean CommissionLuxembourgPublications Office of the European Union2010cited 2018 Mar 15Available fromhttp://www.stopdarmkanker.be/BOEKJE/boekEU.pdfSearch in Google Scholar

8Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011; 128: 3-11. 10.1002/ijc.25654DuffyMJvan RossumLGvan TurenhoutSTMalminiemiOSturgeonCLamerzRUse of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paperInt J Cancer201112831110.1002/ijc.2565420824704Open DOISearch in Google Scholar

9Raffle A, Gray M. Screening: Evidence and Practice. Oxford: University Press; 2007.RaffleAGrayM.Screening: Evidence and PracticeOxfordUniversity Press200710.1093/acprof:oso/9780199214495.001.0001Search in Google Scholar

10Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD, et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 2015; 64: 1257-67. 10.1136/gutjnl-2014-307992SanduleanuSle ClercqCMDekkerEMeijerGARabeneckLRutterMDDefinition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclatureGut20156412576710.1136/gutjnl-2014-30799225193802Open DOISearch in Google Scholar

11Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012; 6: 576-81. 10.1136/gutjnl-2011-300535SteeleRJMcClementsPWatlingCLibbyGWellerDBrewsterDHInterval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour siteGut201265768110.1136/gutjnl-2011-30053521930729Open DOISearch in Google Scholar

12Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100: 259-65. 10.1038/sj.bjc.6604864GrazziniGVisioliCBZorziMCiattoSBanovichFBonanomiAGImmunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?Br J Cancer20091002596510.1038/sj.bjc.6604864263471219142185Open DOISearch in Google Scholar

13Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-9. 10.1136/gut.2010.223982ZorziMFedatoCGrazziniGStoccoFCBanovichFBortoliAHigh sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, ItalyGut201160944910.1136/gut.2010.223982Open DOISearch in Google Scholar

14Tepeš B, Stefanovič M, Bračko M, Frković Grazio S, Maučec Zakotnik J, Novak Mlakar D, et al. [Slovenian colorectal cancer screening programme SVIT - results of pilot phase.] [Slovenian]. Zdrav Vestn 2010; 79: 403-11.TepešBStefanovičMBračkoMFrković GrazioSMaučec ZakotnikJNovak MlakarD[Slovenian colorectal cancer screening programme SVIT - results of pilot phase.] [Slovenian]Zdrav Vestn20107940311Search in Google Scholar

15Tepeš B, Bracko M, Novak Mlakar D, Stefanovic M, Stabuc B, Frkovic Grazio S, et al. Results of the FIT-based National Colorectal Cancer Screening Program in Slovenia. J Clin Gastroenterol 2017; 51: e52-9. 10.1097/MCG.0000000000000662TepešBBrackoMNovak MlakarDStefanovicMStabucBFrkovic GrazioSResults of the FIT-based National Colorectal Cancer Screening Program in SloveniaJ Clin Gastroenterol201751e52910.1097/MCG.0000000000000662Open DOISearch in Google Scholar

16Tepeš B, Kasesnik K, Novak Mlakar D, editos. [Slovenian guidelines of colorectal cancer screening programme SVIT: Slovenian guidelines ensure the quality of colorectal cancer screening.] [Slovenian]. First edition. Ljubljana: Nacionalni inštitut za javno zdravje; 2016.TepešBKasesnikKNovak MlakarD[Slovenian guidelines of colorectal cancer screening programme SVIT: Slovenian guidelines ensure the quality of colorectal cancer screening.] [Slovenian]FirstLjubljanaNacionalni inštitut za javno zdravje2016Search in Google Scholar

17International Classification of Diseases for Oncology, 3rd Edition. Geneva, Switzerland: World Health Organization; 2000.International Classification of Diseases for Oncology3rdGeneva, SwitzerlandWorld Health Organization2000Search in Google Scholar

18Hakama M, Auvinen A, Day NE, Miller AB. Sensitivity in cancer screening. J Med Screen 2007; 14: 174-7. 10.1258/096914107782912077HakamaMAuvinenADayNEMillerAB.Sensitivity in cancer screeningJ Med Screen200714174710.1258/096914107782912077Open DOISearch in Google Scholar

19Malila N, Oivanen T, Malminiemi O, Hakama M. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008; 337: a2261. 10.1136/bmj.a2261MalilaNOivanenTMalminiemiOHakamaM.Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental designBMJ2008337a226110.1136/bmj.a2261Open DOISearch in Google Scholar

20GISCoR Working Group, Zorzi M (Coordinator). Detection of the interval cancers and estimate of the sensitivity of colorectal cancer screening programmes. Working report. Epidemiol Prev 2013; 37 (2-3 Suppl 1) [cited 2018 Mar 15]. Available from: http://www.epiprev.it/materiali/2013/EP2-3/S1_GISCOR/GISCOR_2013_Eng_def.pdfGISCoR Working Group, Zorzi M (Coordinator)Detection of the interval cancers and estimate of the sensitivity of colorectal cancer screening programmes. Working reportEpidemiol Prev2013372-3 Suppl 1cited 2018 Mar 15Available fromhttp://www.epiprev.it/materiali/2013/EP2-3/S1_GISCOR/GISCOR_2013_Eng_def.pdfSearch in Google Scholar

21Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001; 92: 151-4. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1149>3.0.CO;2-6ZappaMCastiglioneGPaciEGrazziniGRubecaTTurcoPMeasuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experienceInt J Cancer200192151410.1002/1097-0215(200102)9999:9999<::AID-IJC1149>3.0.CO26Open DOISearch in Google Scholar

22van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, et al. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. Gastroenterology 2017; 153: 439-47. 10.1053/j.gastro.2017.05.004van der VlugtMGrobbeeEJBossuytPMMBosABongersESpijkerWInterval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical TestingGastroenterology20171534394710.1053/j.gastro.2017.05.004Open DOISearch in Google Scholar

23Portillo I, Arana-Arri E, Idigoras I, Bilbao I, Martínez-Indart L, World LB, et al. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain). J Gastroenterol 2017; 23: 2731-42. 10.3748/wjg.v23.i15.2731PortilloIArana-ArriEIdigorasIBilbaoIMartínez-IndartLWorldLBColorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)J Gastroenterol20172327314210.3748/wjg.v23.i15.2731540375228487610Open DOISearch in Google Scholar

24Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participation. Am J Gastroenterol 2010; 105: 188-98. 10.1038/ajg.2009.583SenoreCArmaroliPSilvaniMAndreoniBBisantiLMaraiLComparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participationAm J Gastroenterol20101051889810.1038/ajg.2009.58319826409Open DOISearch in Google Scholar

25Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, et al. Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain. Gastroenterol Res Pract 2015; 2015: 672410. Published online 2015 Feb 24. 10.1155/2015/672410GarciaMDomènechXVidalCTornéEMilàNBinefaGInterval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, SpainGastroenterol Res Pract20152015672410Published online 2015 Feb 2410.1155/2015/672410435471425802515Open DOISearch in Google Scholar

26Steele RJ, Stanners G, Lang J, Brewster DH, Carey FA, Fraser CG. Interval cancers in a national colorectal cancer screening programme. United European Gastroenterol J 2016; 4: 587-94. 10.1177/2050640615624294SteeleRJStannersGLangJBrewsterDHCareyFAFraserCG.Interval cancers in a national colorectal cancer screening programmeUnited European Gastroenterol J201645879410.1177/2050640615624294497179327536369Open DOISearch in Google Scholar

27Morris EJA, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 2012; 107: 757-64. 10.1038/bjc.2012.331MorrisEJAWhitehouseLEFarrellTNickersonCThomasJDQuirkePA retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening ProgrammeBr J Cancer20121077576410.1038/bjc.2012.331342597422850549Open DOISearch in Google Scholar

28Gill MD, Bramble MG, Rees CJ, Lee TJ, Bradburn DM, Mills SJ. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer 2012; 107: 417-21. 10.1038/bjc.2012.305GillMDBrambleMGReesCJLeeTJBradburnDMMillsSJ.Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening ProgrammeBr J Cancer20121074172110.1038/bjc.2012.305340523022782347Open DOISearch in Google Scholar

29Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H. Early detection of colorectal cancer with faecal occult blood test screening. Br J Surg 2010; 97: 1567-71. 10.1002/bjs.7150PaimelaHMalilaNPalvaTHakulinenTVertioHJärvinenH.Early detection of colorectal cancer with faecal occult blood test screeningBr J Surg20109715677110.1002/bjs.715020603855Open DOISearch in Google Scholar

30Barnett KN, Weller D, Smith S, Steele RJ, Vedsted P, Orbell S, et al. The contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer. Health Expect 2018. 10.1111/hex.12672BarnettKNWellerDSmithSSteeleRJVedstedPOrbellSThe contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancerHealth Expect201810.1111/hex.12672611749429457677Open DOISearch in Google Scholar

31Digby J, Fraser CG, Carey FA, Lang J, Stanners G, Steele RJ. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited. J Med Screen 2016; 23: 130-4. 10.1177/0969141315609634DigbyJFraserCGCareyFALangJStannersGSteeleRJ.Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limitedJ Med Screen201623130410.1177/096914131560963426589788Open DOISearch in Google Scholar